Time filter

Source Type

Saint-André-lez-Lille, France

Ganry O.,Service dEpidemiologie et Sante Publique | Bernin-Mereau A.-S.,Service dEpidemiologie et Sante Publique | Gignon M.,Service dEpidemiologie et Sante Publique | Merlin-Brochard J.,Service dEpidemiologie et Sante Publique | Schmit J.-L.,Service des Maladies Infectieuses
Revue d'Epidemiologie et de Sante Publique | Year: 2013

Background: In France, the human papillomavirus vaccine is routinely recommended for 14-year-old females and a "catch-up" vaccination should be offered to female adolescents who are between 15 and 23 years of age. Currently, few studies are available on the coverage rates in France. The aim of this study was to evaluate the coverage of the human papillomavirus vaccine and compliance with the vaccination scheme in Picardy, between 2009 and 2010, and to analyze the socioeconomic factors possibly influencing this coverage. Methods: We selected a female population that was affiliated with the national health insurance organization, living in the Picardy region of France, and aged between 14 and 23 years on 31st December 2010. Results: The coverage rate in the study population with at least one dose of vaccine was 16.8%. A complete vaccination scheme (three doses) was observed in less than 38.9% of them, so only 6.5% of this population had received the complete vaccination. Higher rates of coverage and compliance were observed in girls 14 years of age (65.5%) and if the prescriber was a gynecologist or pediatrician (respectively, 44.7% and 48.1%). There is a negative correlation between coverage and compliance and the percentage of single-parent families and immigrant families by canton area of Picardy. The economic cost of an inappropriate scheme was 1.3 million euros for Picardy in 2009. Conclusion: Coverage and compliance rates of human papillomavirus vaccines in Picardy appear to be low. This study suggests that health authorities in Picardy should provide communication and action campaigns to improve these results. Position du problème: Méthodes: Résultats: Conclusion: © 2013 Elsevier Masson SAS.

Poisson T.,Service dEpidemiologie et Sante Publique | Dallongeville J.,Service dEpidemiologie et Sante Publique | Evans A.,Queens University of Belfast | Ducimetierre P.,French Institute of Health and Medical Research | And 5 more authors.
European Journal of Clinical Nutrition | Year: 2012

Background/Objectives:In cohort studies, fruit and vegetable (F&V) intake is associated with lower cardiovascular diseases (CVDs). Former smokers often have a higher F&V intake than current smokers. If a high intake of F&V precedes smoking cessation, the latter may explain the favorable association between F&V intake and CVD among smokers. The objective was to assess whether higher F&V intake precedes smoking cessation.Subjects/ Methods:The study population comprised 1056 male smokers from Lille (France) and Belfast (Northern Ireland) aged 5059 years on inclusion in 1991. At baseline, participants completed self-administered questionnaires related to smoking habits, demographic, socioeconomic factors and diet. At the 10-year follow-up, smoking habits were assessed by mailed questionnaire.Results:After 10 years, 590 out of 1056 smokers had quit smoking (70.7% of smoker in Lille and 37.8% in Belfast). After adjusting for center, consumption of F&V was associated with quitting (odds ratio (OR) for high versus low F&V intake: 1.73; 95% confidence interval (CI): (1.222.45); P-trend0.002). After further adjustment for sociodemographic factors, body mass index and medical diet, the association was still statistically significant (OR: 1.59; 95% CI (1.122.27); P-trend0.01). In a model fully adjusted for age, smoking intensity, alcohol consumption and physical activity, the association was no longer significant (P0.14).Conclusions:Higher F&V intake precedes smoking cessation. Hence, smoking cessation could affect the causal interpretation of the association between F&V and CVD in smokers. © 2012 Macmillan Publishers Limited.

Discover hidden collaborations